OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patient access to gene therapy medicinal products: a comprehensive review
Marta Carvalho, Bruno Sepodes, Ana Paula Martins
BMJ Innovations (2020) Vol. 7, Iss. 1, pp. 123-134
Open Access | Times Cited: 11

Showing 11 citing articles:

Future of genetic therapies for rare genetic diseases: what to expect for the next 15 years?
Luiza Amara Maciel Braga, Carlos Gilbert Conte Filho, Fábio Batista Mota
Therapeutic Advances in Rare Disease (2022) Vol. 3
Open Access | Times Cited: 21

The role of public health in rare diseases: hemophilia as an example
Amr El-Sayed, Ulrike M. Reiss, Diana Hanna, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access

Gene Therapy: An Historical Overview for Familial Hearing Loss
O’neil W. Guthrie
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1469-1469
Open Access

Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)
Jennifer E. Adair, Lindsay Androski, Lois Bayigga, et al.
Gene Therapy (2021) Vol. 30, Iss. 3-4, pp. 216-221
Open Access | Times Cited: 23

Drug outcomes research and policies – trends and challenges
Bernd Rosenkranz
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2

Key challenges for hub and spoke models of care – A report from the 1st workshop of the EHC Think Tank on Hub and Spoke Treatment Models
Amanda Bok, Declan Noone, Naja Skouw‐Rasmussen
The Journal of Haemophilia Practice (2022) Vol. 9, Iss. 1, pp. 20-26
Open Access | Times Cited: 10

Gene therapy-based strategies for spinal muscular atrophy—an Asia-Pacific perspective
Michelle A. Farrar, Loudella Calotes-Castillo, Ranil de Silva, et al.
Molecular and Cellular Pediatrics (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 5

“I just wanted to speak to someone- and there was no one…”: using Burden of Treatment Theory to understand the impact of a novel ATMP on early recipients
Ian Litchfield, Melanie Calvert, Francesca Kinsella, et al.
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4

Gesellschaftliche und volkswirtschaftliche Sicht auf die (zukünftige) Finanzierbarkeit von Arzneimitteln
Jürgen Wasem, Theresa Hüer, Carina Abels
Springer eBooks (2021), pp. 19-34
Closed Access | Times Cited: 3

Using analogue data to substantiate long-term durability of gene therapies: a narrative review
Michaela Sharpe, Laura Beswick, Panos Kefalas
Regenerative Medicine (2022) Vol. 17, Iss. 10, pp. 767-782
Closed Access

Understanding stakeholders’ experience with sickle cell disease by social media listening across Europe
Daniel Brás, Celeste Bento, S. Aasaithambi, et al.
Research Square (Research Square) (2022)
Open Access

Page 1

Scroll to top